Skip to main content
. 2023 Sep 12;83(9):1138–1147. doi: 10.1055/a-2150-9440

Fig. 1.

Fig. 1

Twenty-five genomic alterations with potential therapeutical consequences (Level of evidence I-II according to ESMO/ESCAT) detected in 18 metastatic breast cancer patients by next generation sequencing based whole exome sequencing. Five patients had two and one patient three different alterations (CNG = copy number gain, mut = mutation).